{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T21:15:46Z","timestamp":1784754946360,"version":"3.55.0"},"reference-count":39,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Biological Therapy"],"published-print":{"date-parts":[[2025,3,4]]},"DOI":"10.1080\/14712598.2025.2465825","type":"journal-article","created":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T05:17:01Z","timestamp":1739078221000},"page":"221-228","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["An evaluation of linvoseltamab for treatment of relapsed\/refractory multiple myeloma"],"prefix":"10.1080","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1208-9260","authenticated-orcid":false,"given":"Zachary M.","family":"Avigan","sequence":"first","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2939-4385","authenticated-orcid":false,"given":"Mohammad A.","family":"Rattu","sequence":"additional","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0274-0585","authenticated-orcid":false,"given":"Joshua","family":"Richter","sequence":"additional","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,2,16]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27422"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-00359-2"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21820"},{"key":"e_1_3_5_6_1","unstructured":"Cancer stat facts: myeloma. Epidemiology and End Results Program. Janssen Biotech Inc. 2024. Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/mulmy.html"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-01139-y"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2022.100929"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00933-8"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2024850"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2203478"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02528-9"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2204591"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.7528"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.24.01008"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-182388"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-180013"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-157988"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.TPS8064"},{"key":"e_1_3_5_20_1","unstructured":"Tecvayli (teclistamab-cqyv) [Package insert]. Horsham (PA): Janssen Biotech Inc. Available from: https:\/\/www.janssenlabels.com\/package-insert\/product-monograph\/prescribing-information\/TECVAYLI-pi.pdf"},{"key":"e_1_3_5_21_1","unstructured":"Elrexfio (elranatamab-bcmm) [package insert]. NewYork (NY): Pfizer Inc. Available from: https:\/\/labeling.pfizer.com\/ShowLabeling.aspx?id=19669"},{"key":"e_1_3_5_22_1","unstructured":"Talvey (talquetamab-tgvs) [package insert]. Horsham (PA): Janssen Biotech Inc. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/761342s000lbl.pdf"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.7540"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.8034"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-208192"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.136"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.8036"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002736"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep17943"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2016.1160192"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-208776"},{"key":"e_1_3_5_32_1","volume-title":"American Conference on Pharmacometrics","author":"Harnisch L","year":"2024","unstructured":"Harnisch L, Hazra A, Davis J, et al. T-026 a semi-mechanistic population pharmacokinetic (PopPK) model of linvoseltamab with considerations of disease-related factors in patients (Pts) with relapsed\/refractory (RR) multiple myeloma (MM). American Conference on Pharmacometrics; 2024 Nov 12; Phoenix, AZ, USA."},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2152-2650(24)01932-3"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2152-2650(24)01987-6"},{"key":"e_1_3_5_35_1","unstructured":"Linvoseltamab BLA for Treatment of relapsed\/refractory multiple myeloma accepted for FDA priority review. Tarrytown (NY): Regeneron Pharmaceuticals Inc. Available from: https:\/\/investor.regeneron.com\/news-releases\/news-release-details\/linvoseltamab-bla-treatment-relapsedrefractory-multiple-myeloma"},{"key":"e_1_3_5_36_1","unstructured":"Regeneron provides update on biologics license application for linvoseltamab. Tarrytown (NY): Regeneron Pharmaceuticals Inc. Available from: https:\/\/investor.regeneron.com\/news-releases\/news-release-details\/regeneron-provides-update-biologics-license-application-0"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.2165\/11538370-000000000-00000"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2152-2650(24)02304-8"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2152-2650(24)02317-6"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.7536"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-181228"}],"container-title":["Expert Opinion on Biological Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14712598.2025.2465825","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T08:14:26Z","timestamp":1743754466000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14712598.2025.2465825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,16]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3,4]]}},"alternative-id":["10.1080\/14712598.2025.2465825"],"URL":"https:\/\/doi.org\/10.1080\/14712598.2025.2465825","relation":{},"ISSN":["1471-2598","1744-7682"],"issn-type":[{"value":"1471-2598","type":"print"},{"value":"1744-7682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,16]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-11-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}